Drug Delivery

Abstract Medication adherence remains a significant challenge in healthcare, particularly in paediatric populations, where non-adherence has a substantial impact on...

Abstract SmartLipids represent the third generation of lipid-based nanocarriers, emerging as a transformative innovation in modern drug delivery and formulation...

This poster has been presented at the  15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology  which took place in...

Oral delivery, by Gattefossé, remains the most patient friendly route of administration. Yet for peptides, it has long been considered...

Abstract Polymer nanoparticles (PNPs) are compact particulate systems typically ranging from 10 to 1000 nm in size and have emerged...

See two Gattefossé webinars: Gattefossé Pharmaceuticals gathers with Skyepharma and RCPE to decipher the innovative solutions for streamlining nanopharmaceutical production....

CELLETS® in modern pharmaceutical formulations play a central role in multiparticulate drug delivery systems. Today, developers demand excipients that do...

Abstract Background/Objectives: Nanoemulsions (NEs) are a promising platform for transdermal drug delivery (TDD); however, how the polarity of the active pharmaceutical...

Challenges in Pre-Clinical Oral Drug Delivery Pre-clinical studies are essential for evaluating the safety, pharmacokinetics, and efficacy of drug candidates...

Abstract Since the first market authorization of RNA therapies, just eight years ago, the field has witnessed an extraordinary expansion,...